2023 - Research.com Medicine in France Leader Award
His primary areas of study are Transplantation, Internal medicine, Surgery, Immunology and Hematopoietic stem cell transplantation. Gérard Socié has included themes like Aplastic anemia, Cyclophosphamide, Anemia, Histocompatibility and Acute leukemia in his Transplantation study. His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His Surgery research includes themes of Incidence, Cumulative incidence and Hazard ratio. He regularly links together related areas like Stem cell in his Immunology studies. His research integrates issues of Cancer, Hematopoietic cell, Transplantation Conditioning, Fludarabine and Cohort in his study of Hematopoietic stem cell transplantation.
Gérard Socié spends much of his time researching Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Immunology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology. His studies in Gastroenterology integrate themes in fields like Cyclophosphamide and Eculizumab.
He usually deals with Transplantation and limits it to topics linked to Stem cell and Hematology. In his study, which falls under the umbrella issue of Hematopoietic stem cell transplantation, Busulfan is strongly linked to Regimen. The various areas that he examines in his Surgery study include Aplastic anemia and Cohort.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Graft-versus-host disease. His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Cumulative incidence. Within one scientific family, he focuses on topics pertaining to Stem cell under Transplantation, and may sometimes address concerns connected to Cancer research.
In his research, Confidence interval is intimately related to Cohort, which falls under the overarching field of Oncology. His work carried out in the field of Hematopoietic stem cell transplantation brings together such families of science as Hematology, Human leukocyte antigen and Myelofibrosis. The Graft-versus-host disease study combines topics in areas such as Immunology, Bone marrow, Anti-thymocyte globulin and Calcineurin.
His main research concerns Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology. His Transplantation research is multidisciplinary, incorporating elements of Total body irradiation, Cyclophosphamide and Cohort. His Oncology study incorporates themes from Cancer, Haematopoiesis, Stem cell and Risk factor.
His Hematopoietic stem cell transplantation study combines topics in areas such as Myelofibrosis and Metabolomics. His Gastroenterology research integrates issues from Aplastic anemia, Immunosuppression, Tacrolimus, Cumulative incidence and Proportional hazards model. His Graft-versus-host disease research incorporates elements of Calcineurin, Immune system, Immunology, Bone marrow and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo;Emmanuel Payen;Olivier Negre;Gary Wang.
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky.
The New England Journal of Medicine (2006)
Solid Cancers after Bone Marrow Transplantation
Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner.
The New England Journal of Medicine (1997)
Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
Charles Parker;Mitsuhiro Omine;Stephen Richards;Jun-Ichi Nishimura.
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
G Socié;J V Stone;J R Wingard;D Weisdorf.
The New England Journal of Medicine (1999)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger.
Lancet Oncology (2009)
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié.
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp.
British Journal of Haematology (1997)
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
Navneet S. Majhail;Navneet S. Majhail;J. Douglas Rizzo;Stephanie J. Lee;Mahmoud Aljurf.
Biology of Blood and Marrow Transplantation (2012)
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors
Gérard Socié;Jean-Yves Mary;Aimery de Gramont;Bernard Rio.
The Lancet (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: